ArticlePloS one

Retraction: Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.

PLOS ONE EditorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.